A paclitaxel and microRNA-124 coloaded stepped cleavable nanosystem against triple negative breast cancer

A paclitaxel and microRNA-124 coloaded stepped cleavable nanosystem against triple negative breast cancer

Abstract Background Triple negative breast cancer (TNBC) is one of the most biologically aggressive breast cancers and lacks effective treatment options, resulting in a poor prognosis. Therefore, studies aiming to explore new therapeutic strategies for advanced TNBC are urgently needed. According to...

Full description

Bibliographic Details
Main Authors:	Chuanrong Chen, Ming Shen, Hongze Liao, Qianqian Guo, Hao Fu, Jian Yu, Yourong Duan
Format:	Article
Language:	English
Published:	BMC 2021-02-01
Series:	Journal of Nanobiotechnology
Subjects:	Stepped cleavable nanoparticles Paclitaxel MicroRNA-124 Synergistic antitumour effect Triple negative breast cancer
Online Access:	https://doi.org/10.1186/s12951-021-00800-z

Similar Items

Clickable prodrugs bearing potent and hydrolytically cleavable nicotinamide phosphoribosyltransferase inhibitors
by: Sadrerafi K, et al.
Published: (2018-04-01)

Silibinin and Paclitaxel Cotreatment Significantly Suppress the Activity and Lung Metastasis of Triple Negative 4T1 Mammary Tumor Cell in Mice
by: Bing-Ying Ho, et al.
Published: (2012-10-01)

Cleavable PEGylation: a strategy for overcoming the “PEG dilemma” in efficient drug delivery
by: Yan Fang, et al.
Published: (2017-11-01)

Application of Cleavable Linkers to Improve Therapeutic Index of Radioligand Therapies
by: Joseph Lau, et al.
Published: (2022-08-01)

Bone Regeneration Using MMP-Cleavable Peptides-Based Hydrogels
by: Weikai Chen, et al.
Published: (2021-11-01)

Expanding the Scope of the Cleavable <i>N</i>-(Methoxy)oxazolidine Linker for the Synthesis of Oligonucleotide Conjugates
by: Aapo Aho, et al.
Published: (2021-01-01)

Reducing kidney uptake of radiolabelled exendin-4 using variants of the renally cleavable linker MVK
by: Belinda Trachsel, et al.
Published: (2023-09-01)

Novel Silyl Ether-Based Acid-Cleavable Antibody-MMAE Conjugates with Appropriate Stability and Efficacy
by: Yanming Wang, et al.
Published: (2019-07-01)

Drug Synergism of Anticancer Action in Combination with Favipiravir and Paclitaxel on Neuroblastoma Cells
by: Hasan Turkez, et al.
Published: (2023-12-01)

Synergistic effects of flavonoids and paclitaxel in cancer treatment: a systematic review
by: Solmaz Asnaashari, et al.
Published: (2023-09-01)

The prospects for cisplatin and nab-paclitaxel combination therapy in patients with pre-treated triple-negative breast cancer. Description of the clinical case.
by: L. G. Zhukova, et al.
Published: (2018-07-01)

TBCRC 039: a phase II study of preoperative ruxolitinib with or without paclitaxel for triple-negative inflammatory breast cancer
by: Filipa Lynce, et al.
Published: (2024-01-01)

Conditioned Medium of Mesenchymal Stromal Cells Loaded with Paclitaxel Is Effective in Preclinical Models of Triple-Negative Breast Cancer (TNBC)
by: Nicoletta Cordani, et al.
Published: (2023-03-01)

Preparation and anti-triple-negative breast cancer cell effect of a nanoparticle for the codelivery of paclitaxel and gemcitabine
by: Fan Yang, et al.
Published: (2023-09-01)

Self-Assembly Engineering Nanodrugs Composed of Paclitaxel and Curcumin for the Combined Treatment of Triple Negative Breast Cancer
by: Shuting Zuo, et al.
Published: (2021-08-01)

In vivo synergistic anti-tumor effect of paclitaxel nanoparticles combined with radiotherapy on human cervical carcinoma
by: YanXin Yu, et al.
Published: (2017-01-01)

Comparative effectiveness of early-line nab-paclitaxel vs. paclitaxel in patients with metastatic breast cancer: a US community-based real-world analysis
by: Mahtani RL, et al.
Published: (2018-02-01)

Atractylenolide-I Sensitizes Triple-Negative Breast Cancer Cells to Paclitaxel by Blocking CTGF Expression and Fibroblast Activation
by: Meng Wang, et al.
Published: (2021-10-01)

Evaluation of microRNA-124 expression in renal cell carcinoma
by: Çaykara B, et al.
Published: (2021-03-01)

Synergistic combination therapy of lung cancer using paclitaxel- and triptolide-coloaded lipid–polymer hybrid nanoparticles
by: Liu J, et al.
Published: (2018-09-01)

Morphine counteracts the effects of paclitaxel in triple-negative breast cancer cells
by: Gülay Sezer, et al.
Published: (2022-01-01)

Marine Sulfated Polysaccharide PMGS Synergizes with Paclitaxel in Inhibiting Cervical Cancer In Vitro
by: Xuan Xia, et al.
Published: (2023-04-01)

Synthesis and radiolabelling of PSMA-targeted derivatives containing GYK/MVK cleavable linkers
by: Erika Murce, et al.
Published: (2023-03-01)

Construction of Curcumin and Paclitaxel Co-Loaded Lipid Nano Platform and Evaluation of Its Anti-Hepatoma Activity in vitro and Pharmacokinetics in vivo
by: Wei Y, et al.
Published: (2023-04-01)

Silencing of PGK1 Promotes Sensitivity to Paclitaxel Treatment by Upregulating XAF1-Mediated Apoptosis in Triple-Negative Breast Cancer
by: Shanshan Sun, et al.
Published: (2021-03-01)

Developable spaces and cleavability
by: F. CAMMAROTO, et al.
Published: (1994-09-01)

Synergistic Antitumor Activity and Mechanism of Lapatinib and Paclitaxel in Esophageal Cancer Cells
by: CHEN Tao, et al.
Published: (2021-01-01)

Enhanced protein–protein interaction network construction promoted by in vivo cross-linking with acid-cleavable click-chemistry enrichment
by: Lili Zhao, et al.
Published: (2022-11-01)

Pyrazoline B-Paclitaxel or Doxorubicin Combination Drugs Show Synergistic Activity Against Cancer Cells: In silico Study
by: Wiraswati HL, et al.
Published: (2024-02-01)

Antibody-Drug Conjugates: A Promising Novel Therapy for the Treatment of Ovarian Cancer
by: Aranzazu Manzano, et al.
Published: (2020-08-01)

Ascorbyl palmitate-incorporated paclitaxel-loaded composite nanoparticles for synergistic anti-tumoral therapy
by: Min Zhou, et al.
Published: (2017-01-01)

Fiat 124 and 124 Special owners workshop manual/
by: 268832 Haynes, John Harold, et al.
Published: (1976)

Optimizing the enzymatic release of MMAE from isoDGR-based small molecule drug conjugate by incorporation of a GPLG-PABC enzymatically cleavable linker
by: Marco Zambra, et al.
Published: (2023-07-01)

Cellular uptake mechanism and comparative evaluation of antineoplastic effects of paclitaxel–cholesterol lipid emulsion on triple-negative and non-triple-negative breast cancer cell lines
by: Ye J, et al.
Published: (2016-08-01)

The Antitumour Activity of a Curcumin and Piperine Loaded iRGD-Modified Liposome: In Vitro and In Vivo Evaluation
by: Yingzheng Wang, et al.
Published: (2023-09-01)

Investigating the Heterogeneity of Immune Cells in Triple-Negative Breast Cancer at the Single-Cell Level before and after Paclitaxel Chemotherapy
by: Heng Zhao, et al.
Published: (2023-09-01)

Synthesis of amphiphilic poly(ethylene glycol)-block-poly(methyl methacrylate) containing trityl ether acid cleavable junction group and its self-assembly into ordered nanoporous thin films
by: Qi Yinghua, et al.
Published: (2020-03-01)

Aptamer–Gemcitabine Conjugates with Enzymatically Cleavable Linker for Targeted Delivery and Intracellular Drug Release in Cancer Cells
by: Jianjun Qi, et al.
Published: (2022-04-01)

Derivados oleananos e ursanos e sua importância na descoberta de novos fármacos com atividade antitumoral, anti-inflamatória e antioxidante Oleanane and ursane derivatives and their importance on the discovery of potential antitumour, antiinflammatory and antioxidant drugs
by: Luciana Dalla Vechia, et al.
Published: (2009-01-01)

1-Chromonyl-5-Imidazolylpentadienone Demonstrates Anti-Cancer Action against TNBC and Exhibits Synergism with Paclitaxel
by: Karan Modi, et al.
Published: (2020-08-01)